company background image
NUS

Nu Skin Enterprises NYSE:NUS Stock Report

Last Price

US$33.37

Market Cap

US$1.7b

7D

-8.4%

1Y

-19.6%

Updated

02 Oct, 2022

Data

Company Financials +
NUS fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends5/6

NUS Stock Overview

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide.

Nu Skin Enterprises Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nu Skin Enterprises
Historical stock prices
Current Share PriceUS$33.37
52 Week HighUS$56.76
52 Week LowUS$33.29
Beta1.16
1 Month Change-17.13%
3 Month Change-25.38%
1 Year Change-19.55%
3 Year Change-19.80%
5 Year Change-46.81%
Change since IPO16.07%

Recent News & Updates

Sep 27
Returns On Capital Signal Tricky Times Ahead For Nu Skin Enterprises (NYSE:NUS)

Returns On Capital Signal Tricky Times Ahead For Nu Skin Enterprises (NYSE:NUS)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Aug 24
Nu Skin Enterprises (NYSE:NUS) Is Due To Pay A Dividend Of $0.385

Nu Skin Enterprises (NYSE:NUS) Is Due To Pay A Dividend Of $0.385

Nu Skin Enterprises, Inc. ( NYSE:NUS ) will pay a dividend of $0.385 on the 7th of September. This means the annual...

Shareholder Returns

NUSUS Personal ProductsUS Market
7D-8.4%-6.3%-2.5%
1Y-19.6%-33.8%-23.2%

Return vs Industry: NUS exceeded the US Personal Products industry which returned -33.8% over the past year.

Return vs Market: NUS exceeded the US Market which returned -23.2% over the past year.

Price Volatility

Is NUS's price volatile compared to industry and market?
NUS volatility
NUS Average Weekly Movement4.5%
Personal Products Industry Average Movement9.5%
Market Average Movement6.8%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: NUS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: NUS's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19844,600Ryan Napierskihttps://www.nuskin.com

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products.

Nu Skin Enterprises Fundamentals Summary

How do Nu Skin Enterprises's earnings and revenue compare to its market cap?
NUS fundamental statistics
Market CapUS$1.68b
Earnings (TTM)US$113.45m
Revenue (TTM)US$2.48b

14.8x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NUS income statement (TTM)
RevenueUS$2.48b
Cost of RevenueUS$635.68m
Gross ProfitUS$1.84b
Other ExpensesUS$1.73b
EarningsUS$113.45m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)2.25
Gross Margin74.37%
Net Profit Margin4.57%
Debt/Equity Ratio45.4%

How did NUS perform over the long term?

See historical performance and comparison

Dividends

4.6%

Current Dividend Yield

68%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is NUS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NUS?

Other financial metrics that can be useful for relative valuation.

NUS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.7x
Enterprise Value/EBITDA5.7x
PEG Ratio0.7x

Price to Earnings Ratio vs Peers

How does NUS's PE Ratio compare to its peers?

NUS PE Ratio vs Peers
The above table shows the PE ratio for NUS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average26.5x
EPC Edgewell Personal Care
17.8x16.3%US$1.9b
HLF Herbalife Nutrition
5.7x8.4%US$1.9b
USNA USANA Health Sciences
12.1x-2.6%US$1.1b
ELF e.l.f. Beauty
70.5x27.5%US$2.0b
NUS Nu Skin Enterprises
14.8x20.7%US$1.7b

Price-To-Earnings vs Peers: NUS is good value based on its Price-To-Earnings Ratio (14.8x) compared to the peer average (26.5x).


Price to Earnings Ratio vs Industry

How does NUS's PE Ratio compare vs other companies in the US Personal Products Industry?

Price-To-Earnings vs Industry: NUS is expensive based on its Price-To-Earnings Ratio (14.8x) compared to the US Personal Products industry average (14.5x)


Price to Earnings Ratio vs Fair Ratio

What is NUS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NUS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.8x
Fair PE Ratio23x

Price-To-Earnings vs Fair Ratio: NUS is good value based on its Price-To-Earnings Ratio (14.8x) compared to the estimated Fair Price-To-Earnings Ratio (23x).


Share Price vs Fair Value

What is the Fair Price of NUS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NUS ($33.37) is trading below our estimate of fair value ($108.06)

Significantly Below Fair Value: NUS is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies

Future Growth

How is Nu Skin Enterprises forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


20.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NUS's forecast earnings growth (20.7% per year) is above the savings rate (1.9%).

Earnings vs Market: NUS's earnings (20.7% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: NUS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NUS's revenue (2% per year) is forecast to grow slower than the US market (7.7% per year).

High Growth Revenue: NUS's revenue (2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: NUS's Return on Equity is forecast to be high in 3 years time (20.9%)


Discover growth companies

Past Performance

How has Nu Skin Enterprises performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


4.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: NUS has high quality earnings.

Growing Profit Margin: NUS's current net profit margins (4.6%) are lower than last year (8.4%).


Past Earnings Growth Analysis

Earnings Trend: NUS's earnings have grown by 4.9% per year over the past 5 years.

Accelerating Growth: NUS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: NUS had negative earnings growth (-52%) over the past year, making it difficult to compare to the Personal Products industry average (-4.8%).


Return on Equity

High ROE: NUS's Return on Equity (12.1%) is considered low.


Discover strong past performing companies

Financial Health

How is Nu Skin Enterprises's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: NUS's short term assets ($882.9M) exceed its short term liabilities ($384.1M).

Long Term Liabilities: NUS's short term assets ($882.9M) exceed its long term liabilities ($575.7M).


Debt to Equity History and Analysis

Debt Level: NUS's net debt to equity ratio (4.2%) is considered satisfactory.

Reducing Debt: NUS's debt to equity ratio has reduced from 60.7% to 45.4% over the past 5 years.

Debt Coverage: NUS's debt is well covered by operating cash flow (45.4%).

Interest Coverage: NUS's interest payments on its debt are well covered by EBIT (22.9x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Nu Skin Enterprises's current dividend yield, its reliability and sustainability?

Dividend Score

5/6

Dividend Score 5/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


4.61%

Current Dividend Yield

Dividend Yield vs Market

Nu Skin Enterprises Dividend Yield vs Market
How does Nu Skin Enterprises dividend yield compare to the market?
SegmentDividend Yield
Company (Nu Skin Enterprises)4.6%
Market Bottom 25% (US)1.7%
Market Top 25% (US)4.7%
Industry Average (Personal Products)1.3%
Analyst forecast in 3 Years (Nu Skin Enterprises)4.6%

Notable Dividend: NUS's dividend (4.61%) is higher than the bottom 25% of dividend payers in the US market (1.67%).

High Dividend: NUS's dividend (4.61%) is low compared to the top 25% of dividend payers in the US market (4.73%).


Stability and Growth of Payments

Stable Dividend: NUS's dividends per share have been stable in the past 10 years.

Growing Dividend: NUS's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (67.5%), NUS's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (54.5%), NUS's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.2yrs

Average management tenure


CEO

Ryan Napierski (48 yo)

1.33yrs

Tenure

US$4,731,970

Compensation

Mr. Ryan S. Napierski has been Chief Executive Officer of Nu Skin Enterprises Inc. since September 1, 2021. Mr. Napierski has been the President of Nu Skin Enterprises Inc. since March 7, 2017 and has been...


CEO Compensation Analysis

Ryan Napierski's Compensation vs Nu Skin Enterprises Earnings
How has Ryan Napierski's remuneration changed compared to Nu Skin Enterprises's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

US$113m

Mar 31 2022n/an/a

US$139m

Dec 31 2021US$5mUS$801k

US$147m

Sep 30 2021n/an/a

US$230m

Jun 30 2021n/an/a

US$237m

Mar 31 2021n/an/a

US$219m

Dec 31 2020US$4mUS$721k

US$191m

Sep 30 2020n/an/a

US$158m

Jun 30 2020n/an/a

US$146m

Mar 31 2020n/an/a

US$150m

Dec 31 2019US$2mUS$688k

US$174m

Sep 30 2019n/an/a

US$116m

Jun 30 2019n/an/a

US$125m

Mar 31 2019n/an/a

US$129m

Dec 31 2018US$3mUS$621k

US$122m

Sep 30 2018n/an/a

US$158m

Jun 30 2018n/an/a

US$146m

Mar 31 2018n/an/a

US$137m

Dec 31 2017US$3mUS$594k

US$129m

Sep 30 2017n/an/a

US$149m

Jun 30 2017n/an/a

US$165m

Mar 31 2017n/an/a

US$167m

Dec 31 2016US$4mUS$660k

US$143m

Sep 30 2016n/an/a

US$141m

Jun 30 2016n/an/a

US$100m

Mar 31 2016n/an/a

US$100m

Dec 31 2015US$4mUS$538k

US$133m

Compensation vs Market: Ryan's total compensation ($USD4.73M) is about average for companies of similar size in the US market ($USD5.58M).

Compensation vs Earnings: Ryan's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

Experienced Management: NUS's management team is considered experienced (3.2 years average tenure).


Board Members

Experienced Board: NUS's board of directors are seasoned and experienced ( 12.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: NUS insiders have only sold shares in the past 3 months.


Recent Insider Transactions

NYSE:NUS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Sep 22SellUS$62,782James ThomasIndividual1,602US$39.19
18 Aug 22SellUS$257,290Steve HatchettIndividual5,500US$46.78
18 May 22SellUS$1,001,915Steven LundIndividual22,125US$46.07

Ownership Breakdown

What is the ownership structure of NUS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders827,9561.6%
Hedge Funds2,819,3965.6%
General Public4,483,3208.9%
Institutions42,249,93483.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 78.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.18%
State Street Global Advisors, Inc.
9,161,235$305.7m40.5%0.02%
11.71%
The Vanguard Group, Inc.
5,898,315$196.8m-1.69%no data
11.55%
BlackRock, Inc.
5,820,250$194.2m0.5%no data
6.84%
Wellington Management Group LLP
3,444,981$115.0m-6.93%0.02%
5.6%
Renaissance Technologies LLC
2,819,396$94.1m5.56%0.12%
3.51%
Dimensional Fund Advisors LP
1,767,999$59.0m3.4%0.02%
2.18%
Capital Research and Management Company
1,100,000$36.7m0%no data
1.93%
Geode Capital Management, LLC
973,255$32.5m8.35%no data
1.68%
AQR Capital Management, LLC
847,596$28.3m19.97%0.07%
1.64%
Aristotle Capital Boston, LLC
827,449$27.6m2.97%0.86%
1.62%
BNY Mellon Asset Management
818,332$27.3m-0.08%0.01%
1.4%
ProShare Advisors LLC
707,769$23.6m5.5%0.08%
1.35%
Northern Trust Global Investments
678,493$22.6m-2.24%no data
1.1%
Invesco Capital Management LLC
551,756$18.4m12.98%0.01%
1.03%
LSV Asset Management
518,786$17.3m-0.27%0.04%
0.99%
Victory Capital Management Inc.
497,513$16.6m56.75%0.02%
0.93%
Norges Bank Investment Management
469,811$15.7m0%no data
0.87%
Manulife Asset Management
437,032$14.6m-15.58%0.01%
0.85%
Charles Schwab Investment Management, Inc.
428,579$14.3m-0.65%no data
0.83%
Eaton Vance Management
417,746$13.9m0.66%0.01%
0.63%
American Century Investment Management Inc
315,242$10.5m28.52%0.01%
0.47%
Argenta Bank Luxembourg SA
236,112$7.9m-35.94%0.24%
0.46%
Bank of America Corporation, Asset Management Arm
230,755$7.7m614.43%no data
0.45%
Principal Global Investors, LLC
228,831$7.6m13.91%0.01%
0.36%
Bridgewater Associates, LP
180,173$6.0m34.24%0.04%

Company Information

Nu Skin Enterprises, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Nu Skin Enterprises, Inc.
  • Ticker: NUS
  • Exchange: NYSE
  • Founded: 1984
  • Industry: Personal Products
  • Sector: Household
  • Implied Market Cap: US$1.681b
  • Shares outstanding: 50.38m
  • Website: https://www.nuskin.com

Number of Employees


Location

  • Nu Skin Enterprises, Inc.
  • 75 West Center Street
  • Provo
  • Utah
  • 84601
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NUSNYSE (New York Stock Exchange)YesClass A Common StockUSUSDNov 1996
NUSDB (Deutsche Boerse AG)YesClass A Common StockDEEURNov 1996

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/10/02 00:00
End of Day Share Price2022/09/30 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.